Skip to main content

Table 1 Univariate logistical regression analysis

From: Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis

Variable Total Death Survival p OR (95%CI)
Age (years old): 94    0.570 1.510 (0.364, 6.256)
 <  40;   7; 51;   
 ≥ 40   3 33   
Gender: 94    0.259 3.393 (0.407, 28.297)
 Male;   9; 61;   
 Female   1 23   
Fever: 94    0.123 0.109 (0.636, 43.550)
 Yes;   1; 31;   
 No   9 53   
Dizziness: 94    0.136 0.500 (0.604, 41.392)
 Yes;   1; 30;   
 No   9 54   
Headache: 94    0.776 1.230 (0.296, 5.117)
 No;   3; 29;   
 Yes   7 55   
Vomiting: 94    0.732 1.286 (0.305, 5.426)
 No;   7; 63;   
 Yes   3 21   
Memory deficits: 94    0.030 4.500 (1.157, 17.500)
 No;   4; 63;   
 Yes   6 21   
Cognitive impairment: 94    0.133 3.950 (0.657, 23.749)
 No;   8; 79;   
 Yes   2 5   
Disorders of consciousness: 94    0.005 7.400 (1.817, 30.144)
 No;   5; 74;   
 Yes   5 10   
Dysphasia: 94    0.008 6.375 (1.608, 25.274)
 No;   4; 68;   
 Yes   6 16   
Meningeal irritation signs: 94    0.053 6.750 (0.979, 46.551)
 No;   8; 81;   
 Yes   2 3   
Time from symptom onset to presentation: 94    0.193 2.567 (0.621, 10.604)
 < 15 days;   3; 44;   
 ≥15 days   7 40   
ART initiation: 94    0.421 1.731 (0.455, 6.582)
 No;   4; 45;   
 Yes   6 39   
CD4+ T-cell counts: 94    0.005 7.982 (1.880, 33.890)
 ≥ 25 cells/μL;   3; 65;   
 <  25 cells/μL   7 19   
Patchy lesions on MRI: 94    0.192 2.437 (0.639, 9.305)
 No;   4; 52;   
 Yes   6 32   
Ring-enhancing lesions on MRI: 94    0.790 0.833 (0.218, 3.188)
 No;   4; 30;   
 Yes   6 54